Clinical Trial Update: Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System [Phase 1]

View source ↗

Summary

Phase 1 safety feasibility study in humans evaluating the TAXUS Petal Bifurcation Coronary Stent System. The trial is sponsored by Boston Scientific and is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TAXUS Petal Bifurcation Coronary Stent System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Cardiovascular Diseases | Phase 1 | Status: COMPLETED